Rim A. Elbeshbeshy, PharmD
Articles
November 9th 2023
Rituximab Reference vs Biosimilar Utilization for Oncology vs Nononcology Indications
Bonnie A. Labdi, PharmD, BCOP Rim A. Elbeshbeshy, PharmD Michelle Winkler, PhD, MPH Samuel G. Johnson, PharmD, BCPS Rebecca L. Attridge, PharmD, MSc, BCPS, BCCCP
Reporting on the real-world utilization of reference rituximab and its biosimilars can help show prescribing habits and reveal cost-saving opportunities.
Latest Updated Articles
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: November 14th 2024 | Updated: November 15th 2024
Recent Cohorts Aging Into Medicare Use More Counseling and Psychotherapy Than Past Cohorts
Published: September 30th 2024 | Updated: November 15th 2024
Advancing Care for Idiopathic Pulmonary Fibrosis (IPF): Evaluating Current Treatments and Emerging Therapies for Improved Patient Outcomes
